India, April 8 -- At the start of the spread of the COVID-19 pandemic, several Indian companies were extremely concerned as factories began to shut down across swathes of China's industrial heartland and Indian imports from Chinese companies were growing at a fast pace. Indian imports included not just smartphones or consumer electronics, as most suspect, but everything - from toys to batteries and even fuel-injectors, needed to meet the new stricter BS-VI emission norms for vehicles. Then, of course, there was the worry surrounding the pharmaceutical industry as most of the Active Pharmaceutical Ingredients (APIs), required for key drugs, came from China. Indian drug-makers import around 70 per cent of their total bulk drug requirements ...